Bathi operasional sadurunge ngurangi amortisasi: palatin.com (PTN)

Logo grafis palatin.com (PTN)

Palatin Technologies revenues are based on the sale of women's health products and ophthalmological tests. This EBITDA chart visualizes the cash flow, where 0.00 becomes the new value of the metric. However, weak demand and risks in dermatology undermine stability. Limited pricing power for Vyleesi due to insurance limits forces the company to apply significant discounts for sales.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi palatin.com (PTN): kanggo periode 23.11.2025 - 12.11.2026

Palatin Technologies, Inc. (PTN) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Rega bursa Palatin Corp|PTN - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Biji pasar Palatin Technologies|PTN - Nilai Perusahaan
- data nilai buku modal saham:
Nilai Aset Bersih saben Saham Palatin Technologies|PTN - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku palatin.com|PTN - Aset Agregat Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang Agregat marang Ekuitas Palatin Technologies|PTN - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Palatin Technologies Inc|PTN - Utang perusahaan|Rasio utang marang kapitalisasi buku Palatin Technologies|PTN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Palatin Technologies|Rasio likuiditas perantara palatin.com
- rincian bathi lan kelipatan pasar:
PTN - Bathi resik|Prakiraan bathi perusahaan Palatin Technologies|PTN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep palatin.com|PTN - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Palatin Technologies|PTN - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Palatin Technologies|PTN - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan palatin.com|PTN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Palatin Technologies
Analisis kabeh metrik perusahaan:Palatin Corp (PTN)
Produk dadi Palatin Technologies, Inc.

This indicator measures net cash flow from operating activities before taxes and interest payments, allowing for an assessment of the business's actual ability to generate profit. By analyzing the consolidated EBITDA figure, an investor can compare the operating efficiency of Palatin Technologies (PTN) with the commercial success of the drug Vyleesi and the monetization potential of peptide developments through strategic partnerships.

Karo sapa Palatin Technologies saingan

Organon Pharma (OGN) - Bathi sadurunge bunga, pajak, lan amortisasi|DARE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TherapeuticsMD, Inc. (TXMD) - Bathi operasional sadurunge ngurangi amortisasi